Ilyas Kayacioglu
Research Subjects
Research Interests
Ilyas Kayacioglu has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Yavuz Sensoz
Department of Cardiology, Dr. Siyami Ersek Training and Research Hospital, Istanbul, Türkiye
4 shared publications - Yasin Ozden
Department of Cardiovascular Surgery, Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey
3 shared publications - Ferdi Peynirci
Department of Cardiovascular Surgery, Evliya Celebi Training and Research Hospital, Kutahya, Turkiye
2 shared publications - Ahmet Bolukcu
Clinic of Cardiovascular Surgery, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Turkey
1 shared publication - Ahmet Can Topcu
Kosuyolu Adult Cardiac Surgery Quality Improvement Program
1 shared publication - Atilla Kanca
Department of Cardiovascular Surgery, Department of Cardiology, Prof. Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center
1 shared publication
Latest Publications
- Open Access
- 18 September 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (38) , e50738
Early clinical and hemodynamic outcomes of SAVR, Ozaki neocuspidization, and TAVI
Aortic stenosis is a common valvular heart disease associated with substantial morbidity and mortality if left untreated. Surgical aortic valve replacement (SAVR), transcatheter aortic valve implantation (TAVI), and autologous pericardial aortic valve reconstruction (Ozaki procedure) represent alternative interventional strategies, but direct real-world comparisons remain limited. This study evaluated early clinical and 6-month hemodynamic outcomes following these 3 treatment approaches. This retrospective single-center observational study included 153 consecutive patients with severe aortic stenosis treated between December 2020 and March 2022 (SAVR, n = 67; Ozaki, n = 31; TAVI, n = 55). Early mortality was the primary clinical outcome, and 6-month mean transvalvular gradient was the primary echocardiographic outcome. Other clinical and echocardiographic outcomes were considered secondary or exploratory. Multivariable regression, analysis of covariance, and separate pairwise propensity-score matching models were used to account for baseline differences. Propensity scores were estimated using age, sex, EuroSCORE II, chronic kidney disease, and coronary artery disease. TAVI patients were older and had higher operative risk. No statistically significant differences were detected among the groups in early mortality, stroke, or postoperative dialysis. Permanent pacemaker implantation was more frequent after TAVI, while prolonged intensive care unit stay also differed among treatment groups. At 6 months, the Ozaki group showed favorable hemodynamic parameters, including lower mean transvalvular gradients and maximum transvalvular velocity. However, 6-month echocardiographic follow-up was incomplete, and these findings should be considered exploratory given the small Ozaki cohort, baseline differences, and observational study design. SAVR, Ozaki neocuspidization, and TAVI showed distinct early clinical and hemodynamic profiles in this real-world observational cohort. No statistically significant differences were detected in several major early clinical outcomes, although the study was not sufficiently powered to establish equivalent safety or exclude clinically meaningful differences. The favorable short-term hemodynamic findings observed with the Ozaki procedure should be considered hypothesis-generating. Larger prospective studies with longer follow-up are needed to further evaluate comparative clinical outcomes, hemodynamic performance, and durability.
- 18 September 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (38) , e50738
Open AccessEarly clinical and hemodynamic outcomes of SAVR, Ozaki neocuspidization, and TAVI
Aortic stenosis is a common valvular heart disease associated with substantial morbidity and mortality if left untreated. Surgical aortic valve replacement (SAVR), transcatheter aortic valve implantation (TAVI), and autologous pericardial aortic valve reconstruction (Ozaki procedure) represent alternative interventional strategies, but direct real-world comparisons remain limited. This study evaluated early clinical and 6-month hemodynamic outcomes following these 3 treatment approaches. This retrospective single-center observational study included 153 consecutive patients with severe aortic stenosis treated between December 2020 and March 2022 (SAVR, n = 67; Ozaki, n = 31; TAVI, n = 55). Early mortality was the primary clinical outcome, and 6-month mean transvalvular gradient was the primary echocardiographic outcome. Other clinical and echocardiographic outcomes were considered secondary or exploratory. Multivariable regression, analysis of covariance, and separate pairwise propensity-score matching models were used to account for baseline differences. Propensity scores were estimated using age, sex, EuroSCORE II, chronic kidney disease, and coronary artery disease. TAVI patients were older and had higher operative risk. No statistically significant differences were detected among the groups in early mortality, stroke, or postoperative dialysis. Permanent pacemaker implantation was more frequent after TAVI, while prolonged intensive care unit stay also differed among treatment groups. At 6 months, the Ozaki group showed favorable hemodynamic parameters, including lower mean transvalvular gradients and maximum transvalvular velocity. However, 6-month echocardiographic follow-up was incomplete, and these findings should be considered exploratory given the small Ozaki cohort, baseline differences, and observational study design. SAVR, Ozaki neocuspidization, and TAVI showed distinct early clinical and hemodynamic profiles in this real-world observational cohort. No statistically significant differences were detected in several major early clinical outcomes, although the study was not sufficiently powered to establish equivalent safety or exclude clinically meaningful differences. The favorable short-term hemodynamic findings observed with the Ozaki procedure should be considered hypothesis-generating. Larger prospective studies with longer follow-up are needed to further evaluate comparative clinical outcomes, hemodynamic performance, and durability.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (12) , e20240944
Effects of Ozaki procedure on hematological and biochemical parameters
The Ozaki procedure is an open-heart surgery technique used in aortic valve surgery. We investigated the effect of the Ozaki procedure on postoperative hematological and biochemical parameters as in other open-heart surgery applications.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (12) , e20240944
Open AccessEffects of Ozaki procedure on hematological and biochemical parameters
The Ozaki procedure is an open-heart surgery technique used in aortic valve surgery. We investigated the effect of the Ozaki procedure on postoperative hematological and biochemical parameters as in other open-heart surgery applications.
- Open Access
- 4 February 2022
- Published by Elsevier in Journal of Taibah University Medical Sciences
- Vol. 17 (5) , 884-888
The fifth redo operation for mitral paravalvular leakage and free-floating closure device extraction: A case report
- 4 February 2022
- Published by Elsevier in Journal of Taibah University Medical Sciences
- Vol. 17 (5) , 884-888
Open AccessThe fifth redo operation for mitral paravalvular leakage and free-floating closure device extraction: A case report
- 18 October 2018
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 19 (4) , 165-169
Causes of Dyspnea after Cardiac Surgery
Turkthoracj, Turkish Thoracic Journal
- 18 October 2018
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 19 (4) , 165-169
Causes of Dyspnea after Cardiac Surgery
Turkthoracj, Turkish Thoracic Journal
- Open Access
- 15 April 2012
- Published by VM Media Group sp. z o.o in Cardiology Journal
- Vol. 19 (2) , 188-191
An unusual presentation of pericardial cyst: Recurrent syncope in a young patient
Although pericardial cysts are generally benign structures and detected incidentally, they may be associated with life-threatening complications. We present the case of a 24 year-old man with a giant hemorrhagic pericardial cyst diagnosed after evaluation for recurrent syncope which caused compression of the right ventricle. Spontaneous hemorrhage into a pericardial cyst is an extremely rare event, and to our knowledge this is the first case in which a pericardial cyst has been shown to cause recurrent syncope.
- 15 April 2012
- Published by VM Media Group sp. z o.o in Cardiology Journal
- Vol. 19 (2) , 188-191
Open AccessAn unusual presentation of pericardial cyst: Recurrent syncope in a young patient
Although pericardial cysts are generally benign structures and detected incidentally, they may be associated with life-threatening complications. We present the case of a 24 year-old man with a giant hemorrhagic pericardial cyst diagnosed after evaluation for recurrent syncope which caused compression of the right ventricle. Spontaneous hemorrhage into a pericardial cyst is an extremely rare event, and to our knowledge this is the first case in which a pericardial cyst has been shown to cause recurrent syncope.
- Open Access
- 1 January 2003
- Published by Tohoku University Medical Press in The Tohoku Journal of Experimental Medicine
- Vol. 200 (3) , 119-128
Comparative Assessment of Chordal Preservation Versus Chordal Resection in Mitral Valve Replacement for Mitral Stenosis (Long-Term Follow-up: 8 Years)
Carrying out a mitral valve replacement (MVR) while preserving all chordae tendineae in patients with mitral regurgitation has been proven beneficial to the left ventricular performance. To evaluate the effectiveness of this technique in patients with mitral stenosis, a comparison of the echocardiographic data between patients who were operated on using this technique (Group Preservation=GroupP, n=15), and those operated on using the conventional method of MVR (Group Conventional=GroupC, n=15) was made. All patients were examined before surgery, 6 months after surgery and 8 years after surgery. The study population was limited to patients who had no evidence of coronary artery disease, aortic stenosis and-/or regurgitation and patients who had pure mitral stenosis. Echocardiographic measurements obtained both 6 months and 8 years postoperatively revealed a significant decrease in the left ventricular ejection fraction in GroupC (61.33±9.29% preoperatively, 53.2±10.3% postoperatively). The difference between the decrease in the left ventricular ejection fraction of the two groups was statistically significant (−0.71±6.28% in GroupP, −8.07±13.35% in GroupC). There was no evidence of prosthetic valve dysfunction and no operative deaths. Two patients died in GroupP, 3 patients died in GroupC within the 8 year period. The conclusion was reached, that if suitable, mitral valve replacement while preserving the chordae tendineae is expected to have a beneficial effect on postoperative left ventricular performance in patients with mitral stenosis.
- 1 January 2003
- Published by Tohoku University Medical Press in The Tohoku Journal of Experimental Medicine
- Vol. 200 (3) , 119-128
Open AccessComparative Assessment of Chordal Preservation Versus Chordal Resection in Mitral Valve Replacement for Mitral Stenosis (Long-Term Follow-up: 8 Years)
Carrying out a mitral valve replacement (MVR) while preserving all chordae tendineae in patients with mitral regurgitation has been proven beneficial to the left ventricular performance. To evaluate the effectiveness of this technique in patients with mitral stenosis, a comparison of the echocardiographic data between patients who were operated on using this technique (Group Preservation=GroupP, n=15), and those operated on using the conventional method of MVR (Group Conventional=GroupC, n=15) was made. All patients were examined before surgery, 6 months after surgery and 8 years after surgery. The study population was limited to patients who had no evidence of coronary artery disease, aortic stenosis and-/or regurgitation and patients who had pure mitral stenosis. Echocardiographic measurements obtained both 6 months and 8 years postoperatively revealed a significant decrease in the left ventricular ejection fraction in GroupC (61.33±9.29% preoperatively, 53.2±10.3% postoperatively). The difference between the decrease in the left ventricular ejection fraction of the two groups was statistically significant (−0.71±6.28% in GroupP, −8.07±13.35% in GroupC). There was no evidence of prosthetic valve dysfunction and no operative deaths. Two patients died in GroupP, 3 patients died in GroupC within the 8 year period. The conclusion was reached, that if suitable, mitral valve replacement while preserving the chordae tendineae is expected to have a beneficial effect on postoperative left ventricular performance in patients with mitral stenosis.